These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 26126959)

  • 1. Tailored Supersaturable Immediate Release Behaviors of Hypotensive Supersaturating Drug-Delivery Systems Combined with Hot-Melt Extrusion Technique and Self-Micellizing Polymer.
    Yu H; Ma Y; Zhang Y; Zhang H; Zuo L; Hao C; Yu W; Lin X; Zhang Y; Qi X; Shi N
    Polymers (Basel); 2022 Nov; 14(22):. PubMed ID: 36432925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supersaturation-Based Drug Delivery Systems: Strategy for Bioavailability Enhancement of Poorly Water-Soluble Drugs.
    Sharma A; Arora K; Mohapatra H; Sindhu RK; Bulzan M; Cavalu S; Paneshar G; Elansary HO; El-Sabrout AM; Mahmoud EA; Alaklabi A
    Molecules; 2022 May; 27(9):. PubMed ID: 35566319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot Melt Extrusion-Triggered Amorphization as a Continuous Process for Inducing Extended Supersaturable Drug Immediate-Release from saSMSDs Systems.
    Yu H; Zhang Y; Ma Y; Zhang H; Hao C; Zhang Y; Li Z; Qi X; Shi N
    Pharmaceutics; 2022 Mar; 14(4):. PubMed ID: 35456600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Particle Forming Amorphous Solid Dispersions: A Mechanistic Randomized Pharmacokinetic Study in Humans.
    Schittny A; Waldner S; Duthaler U; Vorobyev A; Abramovich R; Krähenbühl S; Puchkov M; Huwyler J
    Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33803049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-by-design in hot melt extrusion based amorphous solid dispersions: An industrial perspective on product development.
    Butreddy A; Bandari S; Repka MA
    Eur J Pharm Sci; 2021 Mar; 158():105655. PubMed ID: 33253883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of increased bioavailability through amorphous solid dispersions: a review.
    Schittny A; Huwyler J; Puchkov M
    Drug Deliv; 2020 Dec; 27(1):110-127. PubMed ID: 31885288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Microenvironment Stimuli-Responsive Polymeric Prodrug Micelles for Improved Cancer Therapy.
    Zhang Z; Yu M; An T; Yang J; Zou M; Zhai Y; Sun W; Cheng G
    Pharm Res; 2019 Dec; 37(1):4. PubMed ID: 31823030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manufacturing Different Types of Solid Dispersions of BCS Class IV Polyphenol (Daidzein) by Spray Drying: Formulation and Bioavailability.
    Panizzon GP; Giacomini Bueno F; Ueda-Nakamura T; Nakamura CV; Dias Filho BP
    Pharmaceutics; 2019 Sep; 11(10):. PubMed ID: 31557831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
    Sun DD; Ju TC; Lee PI
    Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
    van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug release mechanisms from amorphous solid dispersions.
    Park K
    J Control Release; 2015 Aug; 211():171. PubMed ID: 26126959
    [No Abstract]   [Full Text] [Related]  

  • 13. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers.
    Sun DD; Lee PI
    J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilizing pectin interactions for modifying drug release.
    Tiwary AK; Rana V
    Ther Deliv; 2016 Aug; 7(8):517-20. PubMed ID: 27444492
    [No Abstract]   [Full Text] [Related]  

  • 15. Freeze-dried amorphous dispersions for solubility enhancement of thermosensitive API having low molecular lipophilicity.
    Kulthe VV; Chaudhari PD; Aboul-Enein HY
    Drug Res (Stuttg); 2014 Sep; 64(9):493-8. PubMed ID: 24443307
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.